Welcome to MutualFunds.com. Please help us personalize your experience.
Thank you for your submission, we hope you enjoy your experience

Select the one that best describes you
Mutualfunds logo

JNGLX Janus Global Life Sciences D

  • Fund
  • JNGLX
  • Price as of: Aug 08, 2016
  • $50.90
  • - $0.58
  • - 1.13%
  • Category
  • Health & Biotech Equities

JNGLX - Profile

Vitals

  • YTD Return -2.6%
  • 3 Yr Annualized Return 18.5%
  • 5 Yr Annualized Return 21.8%
  • Net Assets $3.86 B
  • Holdings in Top 10 28.4%

52 WEEK LOW AND HIGH

$50.90
$42.05
$57.86

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.85%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 47.00%

TRADING FEES

  • Max Redemption Fee 2.00%

Min Investment

Closed to new investors as of 2010-02-12

STANDARD (TAXABLE)

$2,500

IRA

$1,000

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -2.6%
  • 3 Yr Annualized Total Return 18.5%
  • 5 Yr Annualized Total Return 21.8%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.07%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name Janus Global Life Sciences Fund
  • Fund Family Name Janus
  • Inception Date Dec 31, 1998
  • Shares Outstanding N/A
  • Share Class D
  • Currency USD
  • Domiciled Country United States
  • Manager Andrew Acker

Fund Description

The Janus Global Life Sciences Fund Class D (JNGLX) is a low-cost, actively managed fund focused on the health care sector. The fund holds a wide range of health care-related equities from around the world and can invest in any market-cap size. JNGLX balances its investments in the biotech, traditional pharmaceuticals and health care equipment/services sphere in order to help reduce volatility.

As a specialized health care fund, JNGLX should only be used as a satellite position in a broader equity portfolio. The fund is managed by Janus Capital Management.

JNGLX - Performance

Return Ranking - Trailing

Period JNGLX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -2.6% -25.2% 18.9% 45.54% 3
1 Yr -14.8% -29.1% 15.0% 69.64% 4
3 Yr 18.5% * 4.7% 22.2% 2.75% 1
5 Yr 21.8% * 10.5% 23.7% 7.62% 1
10 Yr 13.4% * 8.3% 16.3% 26.73% 2

* Annualized


Return Ranking - Calendar

Period JNGLX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -0.8% -20.4% 13.8% 32.11% 2
2014 N/A 13.1% 21.8% N/A N/A
2013 N/A 30.6% 65.2% N/A N/A
2012 N/A 9.6% 27.7% N/A N/A
2011 N/A -1.8% 18.0% N/A N/A

Total Return Ranking - Trailing

Period JNGLX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -2.6% -25.2% 18.9% 45.54% 3
1 Yr -14.8% -32.7% 15.0% 63.39% 4
3 Yr 18.5% * 3.2% 22.2% 2.75% 1
5 Yr 21.8% * 9.9% 23.7% 5.71% 1
10 Yr 13.4% * 8.0% 16.3% 25.74% 2

* Annualized


Total Return Ranking - Calendar

Period JNGLX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 -0.8% -20.4% 13.8% 32.11% 2
2014 N/A 17.6% 22.2% N/A N/A
2013 N/A 51.1% 71.1% N/A N/A
2012 N/A 19.8% 39.6% N/A N/A
2011 N/A 13.8% 20.1% N/A N/A

NAV & Total Return History

JNGLX - Holdings

Filings data as of: Jun 30, 2016

Concentration Analysis

JNGLX Category Low Category High JNGLX % Rank Quintile
Net Assets 3.86 B 23.8 M 50.7 B 7.14% 1
Number of Holdings 96 30 356 13.39% 2
Net Assets in Top 10 1.1 B 9.08 M 20.2 B 11.61% 2
Weighting of Top 10 28.4% 22.2% 68.4% 33.04% 5

Top 10 Holdings

  1. Celgene Corp 3.09%
  2. Amgen Inc 3.57%
  3. Allergan PLC 2.61%
  4. Sanofi SA 2.47%
  5. Aetna Inc 2.69%
  6. Bristol-Myers Squibb Company 3.16%
  7. Universal Health Services Inc Class B 2.39%
  8. Eli Lilly and Co 3.01%
  9. Pfizer Inc 2.95%
  10. AstraZeneca PLC 2.44%

Asset Allocation

Weighting Category Low Category High JNGLX % Rank Quintile
Stocks
96.18% 87.51% 106.76% 25.00% 4
Other
2.31% -6.76% 2.31% 0.89% 1
Cash
1.19% 0.00% 12.50% 16.96% 3
Convertible Bonds
0.33% 0.00% 0.33% 0.89% 1
Preferred Stocks
0.00% 0.00% 1.48% 4.46% 3
Bonds
0.00% 0.00% 1.19% 3.57% 3

Stock Sector Breakdown

Weighting Category Low Category High JNGLX % Rank Quintile
Healthcare
92.52% 14.93% 99.47% 26.79% 4
Technology
3.15% 0.00% 64.47% 6.25% 2
Industrials
0.50% 0.00% 12.74% 8.93% 2
Financial Services
0.00% 0.00% 1.13% 6.25% 3
Utilities
0.00% 0.00% 1.25% 1.79% 3
Real Estate
0.00% 0.00% 1.99% 1.79% 3
Energy
0.00% 0.00% 0.00% 0.89% 3
Communication Services
0.00% 0.00% 2.23% 1.79% 3
Consumer Defense
0.00% 0.00% 2.38% 12.50% 4
Consumer Cyclical
0.00% 0.00% 4.23% 6.25% 3
Basic Materials
0.00% 0.00% 2.05% 3.57% 3

Stock Geographic Breakdown

Weighting Category Low Category High JNGLX % Rank Quintile
US
76.70% 62.67% 99.85% 28.57% 4
Non US
19.48% 0.14% 44.09% 7.14% 1

JNGLX - Expenses

Operational Fees

JNGLX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 0.85% 0.10% 4.31% 58.93% 1
Management Fee 0.64% 0.08% 1.25% 13.39% 2
12b-1 Fee N/A 0.00% 1.00% N/A N/A
Administrative Fee 0.12% 0.01% 0.40% 7.69% 3

Sales Fees

JNGLX Fees (% of AUM) Category Low Category High JNGLX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

JNGLX Fees (% of AUM) Category Low Category High JNGLX Rank Quintile
Max Redemption Fee 2.00% 0.75% 2.00% 2.27% 5

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

JNGLX Fees (% of AUM) Category Low Category High JNGLX Rank Quintile
Turnover 47.00% 4.00% 249.00% 12.50% 3

JNGLX - Distributions

Dividend Yield Analysis

JNGLX Category Low Category High JNGLX % Rank Quintile
Dividend Yield 0.0% 0.01% 0.94% 65.96% 4

Dividend Distribution Analysis

JNGLX Category Low Category High Category Mode
Dividend Distribution Frequency Semi-Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

JNGLX Category Low Category High JNGLX % Rank Quintile
Net Income Ratio -0.07% -2.26% 1.24% 16.96% 2

Capital Gain Distribution Analysis

JNGLX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

JNGLX - Managers

Andrew Acker

Manager

Start Date

May 01, 2007

Tenure

9.26

Tenure Rank

10.1%

Andrew Acker, CFA, is Executive Vice President and Portfolio Manager , which he has managed since May 2007. Mr. Acker is also Portfolio Manager of other Janus accounts and performs duties as a research analyst. He joined Janus Capital in 1999 as a securities analyst. Mr. Acker holds a Bachelor of Science degree (magna cum laude) in Biochemical Sciences from Harvard College where he was a member of Phi Beta Kappa. He also holds a Master’s degree in Business Administration with honors from Harvard Business School. Mr. Acker holds the Chartered Financial Analyst designation.


Ethan Lovell

Manager

Start Date

Jan 12, 2016

Tenure

0.55

Tenure Rank

21.1%

Ethan Lovell is an equity research analyst primarily focusing on the global pharmaceutical industry. Mr. Lovell also serves as a co-team leader of the health care sector research team and is assistant portfolio manager on the Janus Global Life Sciences strategy. Mr. Lovell joined Janus Capital as a research analyst in August 2007. Mr. Lovell holds a Bachelor of Arts degree from Bowdoin College with a double major in Chemistry and Economics and a Master’s degree in Business Administration from Tulane University.


Tenure Analysis

Category Low

0.1

Category High

18.9

Category Average

8.99

Category Mode

1.6